MicroFat injections will be compared with corticosteroid injections for treating pain and function of patients with moderate knee osteoarthritis, according to a Jan. 13 news release. Yogesh Mittal, MD, of The Orthopaedic Clinic in Tulsa, Okla. enrolled the study’s first patient.
Up to 20 sites will be involved in the study. Lipogems’ injections serve as an alternative to total knee replacement.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
